Delray Medical Center Celebrates Dr. Christopher Tallman Completing 200 Aquablation Procedures

Fri September 18, 2026

Milestone highlights hospital’s experience with advanced, minimally invasive treatment for enlarged prostate

Delray Medical Center is celebrating a significant milestone in men’s health as Christopher Tallman, M.D., has completed 200 Aquablation therapy procedures at the hospital, providing men with an advanced treatment option for benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate.

BPH is a noncancerous enlargement of the prostate that becomes increasingly common as men age. The condition can cause frequent or urgent urination, difficulty starting urination, a weak urine stream and the feeling that the bladder has not completely emptied. For some men, symptoms can significantly interfere with sleep and everyday activities.

Aquablation therapy is a minimally invasive treatment that uses a heat-free waterjet controlled with robotic technology to remove targeted prostate tissue. The procedure combines real-time imaging with a physician-created treatment plan, allowing the surgeon to identify the tissue that needs to be removed while helping preserve surrounding anatomy.

“Completing 200 Aquablation procedures is an exciting milestone, but what is most rewarding is seeing the difference this treatment can make in the lives of our patients,” said Dr. Tallman. “Many men live with the symptoms of an enlarged prostate for years before seeking treatment. Aquablation gives us another advanced option to provide lasting symptom relief while creating a treatment plan specifically designed around each patient’s anatomy.”

Aquablation therapy can be used to treat prostates across a range of sizes and provides an alternative for appropriate patients who have not experienced sufficient relief from medication or are looking for another option beyond traditional surgical treatments.

The technology allows physicians to map the prostate and determine which tissue should be removed before the waterjet portion of the procedure begins. Once the treatment plan is established, a robotically controlled, heat-free waterjet removes the targeted tissue.

“Dr. Tallman reaching 200 Aquablation procedures demonstrates the level of experience and expertise we continue to build at Delray Medical Center,” said Heather Havericak, chief executive officer of Delray Medical Center. “We are committed to investing in innovative technologies that give our physicians more options to personalize care and help our patients get back to the activities they enjoy. This milestone is another example of how we are expanding access to advanced care for men throughout our community.”

The milestone further strengthens Delray Medical Center’s growing portfolio of minimally invasive and technology-assisted procedures designed to improve treatment options and the patient experience.

About Delray Medical Center

Delray Medical Center, part of the Palm Beach Health Network, is a 536-bed acute care hospital, spanning 30 acres, employing over 1,700 employees, 700 physicians, serving southern Palm Beach County for over 40 years. As both a community hospital and state-designated Level I Trauma Center Delray Medical Center offers several specialized services including state-of-the art cardiac and vascular facilities, orthopedics, neurosciences, emergency care, and weight-loss surgery.

Pinecrest Rehabilitation and Outpatient Hospital at Delray Medical Center is the only state designated brain and spinal cord injury rehabilitation program in the county by the State of Florida. Delray Medical Center is also home to Fair Oaks Pavilion, a 53-bed adult psychiatry unit. For more information about our services, visit our website at www.palmbeachhealthnetwork.com.

Continue